Bridgefront Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $332K | Sell |
20,721
-15,338
| -43% | -$245K | 0.09% | 399 |
|
|
2025
Q1 | $616K | Buy |
+36,059
| New | +$616K | 0.18% | 198 |
|
|
2022
Q3 | – | Sell |
-15,649
| Closed | -$61K | – | 385 |
|
|
2022
Q2 | $61K | Sell |
15,649
-3,353
| -18% | -$13.1K | 0.07% | 280 |
|
|
2022
Q1 | $105K | Buy |
+19,002
| New | +$105K | 0.13% | 232 |
|
|
2021
Q3 | – | Sell |
-13,612
| Closed | -$144K | – | 506 |
|
|
2021
Q2 | $144K | Buy |
+13,612
| New | +$144K | 0.05% | 535 |
|